TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Opyl Ltd. ( (AU:PKY) ) just unveiled an announcement.
Pathkey.AI Ltd has requested a trading halt on its securities pending a significant announcement regarding a capital raising. This move is intended to allow the company time to consider, plan, and execute the capital raising, which is expected to impact its operations and market positioning by potentially providing additional resources for its AI-driven clinical trial optimization efforts.
More about Opyl Ltd.
Pathkey.AI Limited (ASX: PKY) is an Australian technology company focused on enhancing clinical trials through artificial intelligence. Their core platform, TrialKey, is an AI-powered tool that predicts clinical trial success and aids in optimizing trial design and planning, aiming to transform drug development by minimizing risk and improving resource allocation.
Average Trading Volume: 1,083,648
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.24M
See more data about PKY stock on TipRanks’ Stock Analysis page.